ALFA Filings
Every announcement, straight from the exchange
Every Syncom Formulation (India) other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Syncom Formulations (India) Limited filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.
Syncom Formulations (India) Limited informed exchanges about the dispatch of letters to shareholders with unregistered email addresses, providing instructions to access the 38th AGM Notice and Annual Report.
Syncom Formulations appointed M/s M. Goyal & Co. as Cost Auditor and M/s Bansal & Agrawal as Internal Auditor for FY 2026-27.